Geneos Wealth Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2K | Sell |
1,365
-2,011
| -60% | -$18K | ﹤0.01% | 2242 |
|
|
2025
Q1 | $25.3K | Buy |
3,376
+2,554
| +311% | +$19.2K | ﹤0.01% | 2230 |
|
|
2024
Q4 | $6.18K | Sell |
822
-500
| -38% | -$3.76K | ﹤0.01% | 2249 |
|
|
2024
Q3 | $10K | Buy |
1,322
+822
| +164% | +$6.25K | ﹤0.01% | 1844 |
|
|
2024
Q2 | $3.09K | Hold |
500
| – | – | ﹤0.01% | 1805 |
|
|
2024
Q1 | $2.54K | Hold |
500
| – | – | ﹤0.01% | 1859 |
|
|
2023
Q4 | $3K | Buy |
+500
| New | +$3K | ﹤0.01% | 1848 |
|
|
2020
Q3 | – | Sell |
-1,200
| Closed | -$5K | – | 2632 |
|
|
2020
Q2 | $5K | Buy |
+1,200
| New | +$5K | ﹤0.01% | 2127 |
|